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Introduction: In vivo studies of brain metabolism under transient ischemia are essential to understand the mechanisms of related tissue death. The 
focal model of middle cerebral artery occlusion (MCAO) is very useful for longitudinal examination of ischemic effects both in ischemic core and 
penumbra and more distant regions. So far, in vivo magnetic resonance spectroscopic (MRS) studies of MCAO in mice have been limited to either 
single-voxel spectroscopy or MRS imaging (MRSI) with a relatively coarse spatial resolution and restricted spectral information; most MRSI studies 
up to date only quantify N-acetyl-aspartate (NAA), total creatine (tCr), lactate (Lac), total cholines (tCho) and the sum of glutamate (Glu) and 
glutamine (Gln). At lower magnetic field strengths, extremely long acquisition times are necessary to achieve sufficient signal-to-noise ratio (SNR) 
and spectral resolution allows for quantification of only a limited number of metabolites. High-field MRSI of mouse brain is feasible despite other 
challenges, such as increased field inhomogeneity. A recent LASER-MRSI study1 on a vertical bore 17.6T magnet quantified a slightly larger set of 
metabolites. Comparative studies2 have demonstrated that standard MRSI (one TR per k-space point) is optimal in terms of sensitivity per time, so it 
is desirable to stick to this scheme as closely as possible while tailoring the method to fit the needs of setup and investigated model. 
Our aim was to adopt an optimized protocol with k-space weighted acquistion and ultra-short echo time (TE) at very high magnetic field strength to 
measure the spatial distribution of the neurochemical profile after transient ischemia in mice within a reasonable measurement time.  
Experimental: Seven male iCD-CR mice underwent a protocol of 30min transient MCAO and were transferred to an MRI system (Varian, Palo 
Alto, CA, USA) after 3, 8 and 24h of reperfusion. Six mice served as control group. The MRI system was interfaced to a 14.1T magnet with a 26-cm 
horizontal bore (Magnex Scientific, Oxford, UK). A home-built quadrature surface coil was used as transceiver. T2-images were acquired with a FSE 
multislice method3 to position the volume of interest (VOI) for subsequent MRSI and to detect abnormal T2-hyperintense signals, i.e. ischemic 
edema. A 1.5mm thick coronally oriented VOI of 4mm×6mm was selected for excitation at 0.4mm anterior to the bregma (Fig. 1). The echoplanar 
FASTMAP version was used for first- and second-order corrections of the magnetic field in the VOI as in Ref. 4. For MRSI, we combined the 
SPECIAL technique5 (TE=2.8ms) and an accelerated k-space acquisition scheme6 with a circular sampling window and a relatively flat 2D Hamming 
filter weighting the TRs, calculated from the T1 of metabolites (about 1500ms at 14.1T) and water (T1≈2000ms) respectively7,8. Maximum TR at the 
k-space center was 2500ms for metabolites and 1600ms for water. The acquired data were filled into a 32×32 matrix covering a 19mm×19mm FOV 
in the coronal plane. Corners of k-space were zero-filled and data were multiplied with another Hamming-shaped filter so total filtering corresponded 
to the standard Hamming filter. The resulting effective full width at half maximum (FWHM) voxel size was 1.4μl. Outer volume saturation and 
VAPOR water suppression were used for the metabolite acquisition. Acquisition time was 45min for metabolites and 30min for the water reference.  
Results: Water linewidths were 25±3 Hz for the whole excited volume and ≥ 10.2 Hz for individual voxels at 
SNR values up to 17. Spectra of individual voxels allowed for quantification of 15 metabolites (Fig. 2) plus 
macromolecules with a CRLB of less than 20%. The resulting values were within error ranges of a previous 
single-voxel 1H MRS study9. Large concentration changes in the ischemic striatum could be observed for 
most quantifiable components of the neurochemical profile, e.g. NAA, taurine (Tau) and Glu (Fig.3). The 
extent of the drop in NAA did not correlate with the increase in Lac (p>0.6). tCr and GABA, NAA and Tau 
showed a similar pattern of significant temporal decrease. The behavior of GSH was similar to that of Glu, 
i.e., its decrease compared to the contralateral side was the same at all time points (2.0±0.3 vs. 0.9±0.3 μmol/g 
in contra- vs. ipsilateral striatum, p<0.0001). GSH and tCho were decreased in the entire MCAO territory 
whereas changes in Lac, NAA, Glu and GABA were more restricted to the site of T2-hyperintensity. While in 
healthy control animals no voxel in the entire MRSI map showed Gln concentrations higher 
than 4 μmol/g, Gln was significantly increased in striatum and cortex of the ischemic 
hemisphere (all p<0.05) at 3h and 8h. The concentration peaked at 8h (7.5±0.3 µmol/g in 
striatum, 8.6±1.4 µmol/g in cortex, see Figure 6) and returned to a normal level in striatum at 
24h while remaining significantly increased in cortex (p<0.01). 
Discussion and Conclusions: Optimizing the sensitivity per time on a high-end machine 
yielded metabolite maps of excellent spatial resolution and spectral quantification. To our 
knowledge this study is the first to provide 1H-MRSI maps of GABA and GSH and also one 
of the few mapping Glu and Gln separately at high spatial resolution. Our results are in good 
agreement with single-voxel MRS and give new insights e.g. concerning the distribution of 
GSH which we found to be reduced in the entire territory of the occluded MCA which is 
different from results of a recent microscopy study10 that suggested increased GSH in the 
penumbra. Also the protocol is suitable for the further analysis of Gln in different tissues. 
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Fig. 2: Spectrum from 1.4µl voxel, healthy striatum
Fig. 3: Maps of example metabolites at 3h, note 
e.g. high hypothalamic GABA and widely 
increased Gln in the ischemic area 
Fig. 1: VOI used for MRSI depicted 
on T2-weighted image at 24h 
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